Rocket Pharmaceuticals Inc (RCKT)

NASDAQ

$3.43

Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey.

Website: https://www.rocketpharma.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Hold

Target: $9.39 (+173.76%)

Market Cap

$398M

Free Cash Flow Yield

-45.17%

Beta (5Y)

1.35

Price Chart

Adjust inflation

Log

Valuation

Market Cap$398M

P/B1.67

Profitability

EBITDA-$208M

EPS-$1.93

Financial Health

Free Cash Flow Yield-45.17%

Growth & Risk

EPS 5Y CAGR-5.96%

FCF 5Y CAGR+14.24%

Beta (5Y)1.35

Sharpe Ratio0.35